Bright Minds Biosciences Inc. SEC filings DRUG
Bright Minds Biosciences Inc. has 180 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form 40-F, was filed on Dec 23, 2025 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 2, 2025 | — |
| CORRESP | Letter to the SEC | Aug 28, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 27, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 12, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2025 | — |
| D | Filing | Nov 19, 2024 | — |
| D | Filing | Oct 22, 2024 | — |
| D | Filing | May 3, 2024 | — |
| D | Filing | Sep 14, 2022 | — |
| D | Filing | Sep 1, 2022 | — |
| D | Filing | May 3, 2022 | — |
| D | Filing | May 3, 2022 | — |
| CERT | 8a cert | Nov 4, 2021 | — |
| 8-A12B | Form 8-a12b | Nov 2, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| 20FR12G/A | Form 20fr12g/a | Sep 17, 2021 | — |
| CORRESP | Letter to the SEC | Sep 16, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2021 | — |
| CORRESP | Letter to the SEC | Aug 27, 2021 | — |
| 20FR12G/A | Form 20fr12g/a | Aug 27, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2021 | — |
| CORRESP | Letter to the SEC | Aug 13, 2021 | — |
| 20FR12G/A | Form 20fr12g/a | Aug 13, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2021 | — |
| 20FR12G/A | Form 20fr12g/a | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2021 | — |
| D | Filing | Jun 25, 2021 | — |
| 20FR12G | Form 20fr12g | Jun 17, 2021 | — |
| D | Filing | May 4, 2021 | — |
| D | Filing | Mar 23, 2021 | — |
| D | Filing | Nov 17, 2020 | — |
| D | Filing | Nov 17, 2020 | — |
| D | Filing | Oct 7, 2020 | — |
| D | Filing | Oct 6, 2020 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DRUG (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Chicago, IL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1827401
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.